C. David Nicholson
2017
In 2017, C. David Nicholson earned a total compensation of $11.1M as Chief R&D Officer at Allergan.
Compensation breakdown
| Change in Pension Value and Nonqualified Deferred Compensation Earnings | $5 |
|---|---|
| Non-Equity Incentive Plan | $3,022,500 |
| Salary | $837,158 |
| Stock Awards | $7,162,716 |
| Other | $30,387 |
| Total | $11,052,765 |
Nicholson received $7.2M in stock awards, accounting for 65% of the total pay in 2017.
Nicholson also received $5 of change in pension value and nonqualified deferred compensation earnings, $3M in non-equity incentive plan, $837.2K in salary and $30.4K in other compensation.
Rankings
In 2017, C. David Nicholson's compensation ranked 533rd out of 14,666 executives tracked by ExecPay. In other words, Nicholson earned more than 96.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 533 out of 14,666 | 96th |
Division Manufacturing | 175 out of 5,772 | 97th |
Major group Chemicals And Allied Products | 41 out of 2,075 | 98th |
Industry group Drugs | 30 out of 1,731 | 98th |
Industry Pharmaceutical Preparations | 26 out of 1,333 | 98th |
Source: SEC filing on March 23, 2018.
Nicholson's colleagues
We found four more compensation records of executives who worked with C. David Nicholson at Allergan in 2017.